logo
S&P 500 at Record Highs. Should You Buy?

S&P 500 at Record Highs. Should You Buy?

Many investors were shaken out of their positions in April as the stock market plunged on tariff and inflation fears. However, both the S&P 500 ETF (SPY) and the Nasdaq 100 ETF (QQQ) have mounted incredible comebacks and are up by 26% and 34%, respectively, since April 8.
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The 'lockout rally', or a surge in price in which many people are too scared to buy in given concerns about the economy, has resulted in many investors missing out on elevated gains. So, with the market at all-time highs, is it too late to buy?
Buying the S&P 500 on a Record-High Day Pays Off
Buying the S&P 500 on a record-high day offers greater long-term performance than buying on any other day, according to data from J.P. Morgan.
Buying the benchmark index on a record-high day yields a three-month return of 2.3% and a six-month return of 5.9%. Buying the index on any other day provides a three-month return of 2.9% and a six-month return of 5.8%.
The outperformance of buying on a record-high day increases as the time period lengthens. The one-year return for buying at a record-high is 13.4% compared to 11.9% for any other day. The three-year return for buying at a record-high is 48.1% compared to 40.2%. And for five years out? 79.6% compared to 73.8%.
In other words, it isn't too late to join in on the rally.
The S&P 500 (SPX) has returned 6.76% year-to-date.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Macquarie Reaffirms Their Hold Rating on Medibank Private (MDBPF)
Macquarie Reaffirms Their Hold Rating on Medibank Private (MDBPF)

Business Insider

time22 minutes ago

  • Business Insider

Macquarie Reaffirms Their Hold Rating on Medibank Private (MDBPF)

In a report released today, Andrew Buncombe from Macquarie maintained a Hold rating on Medibank Private, with a price target of A$4.50. The company's shares closed last Tuesday at $3.22. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Buncombe is a 4-star analyst with an average return of 10.6% and a 72.73% success rate. Buncombe covers the Financial sector, focusing on stocks such as NIB Holdings Ltd, ASX , and Insurance Australia Group Limited. In addition to Macquarie, Medibank Private also received a Hold from Jarden's Daniel Bui in a report issued on July 3. However, on July 1, Morgan Stanley upgraded Medibank Private (Other OTC: MDBPF) to a Buy. Based on Medibank Private's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $4.39 billion and a net profit of $340.3 million. In comparison, last year the company earned a revenue of $4.09 billion and had a net profit of $343.2 million

Macquarie downgrades Boss Energy (BQSSF) to a Hold
Macquarie downgrades Boss Energy (BQSSF) to a Hold

Business Insider

time22 minutes ago

  • Business Insider

Macquarie downgrades Boss Energy (BQSSF) to a Hold

In a report released today, from Macquarie downgraded Boss Energy to a Hold, with a price target of A$4.45. The company's shares closed last Thursday at $2.84. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. In addition to Macquarie, Boss Energy also received a Hold from Jefferies's Daniel Roden in a report issued on July 2. However, on the same day, J.P. Morgan maintained a Buy rating on Boss Energy (Other OTC: BQSSF). The company has a one-year high of $3.11 and a one-year low of $1.26. Currently, Boss Energy has an average volume of 25.78K.

Canaccord Genuity Reaffirms Their Buy Rating on Nanosonics Limited (NNCSF)
Canaccord Genuity Reaffirms Their Buy Rating on Nanosonics Limited (NNCSF)

Business Insider

time22 minutes ago

  • Business Insider

Canaccord Genuity Reaffirms Their Buy Rating on Nanosonics Limited (NNCSF)

In a report released on July 2, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Nanosonics Limited, with a price target of A$5.15. The company's shares closed last Tuesday at $2.68. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Shapiro covers the Healthcare sector, focusing on stocks such as Mayne Pharma Group, Cogstate Ltd, and Immutep Ltd. According to TipRanks, Shapiro has an average return of -10.5% and a 34.31% success rate on recommended stocks. Nanosonics Limited has an analyst consensus of Hold, with a price target consensus of $3.29. The company has a one-year high of $3.45 and a one-year low of $1.69. Currently, Nanosonics Limited has an average volume of 4,975. Based on the recent corporate insider activity of 6 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of NNCSF in relation to earlier this year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store